Literature DB >> 26924906

Correlation of Endometrial Thickness with the Histopathological Pattern of Endometrium in Postmenopausal Bleeding.

Pushpa Singh1, Pooja Dwivedi2, Shweta Mendiratta1.   

Abstract

BACKGROUND: Menopause is the permanent cessation of menstruation resulting from the loss of ovarian follicular activity. Bleeding that occurs 12 months after the last menstrual period is labeled as postmenopausal bleeding. AIMS &
OBJECTIVES: The aim of the present study was to study endometrial thickness by transvaginal sonography, and correlate it with the cytological pattern evaluated by endometrial aspiration and histopathological pattern of the hysteroscopic directed biopsy.
RESULTS: Sixty patients presenting with postmenopausal bleeding in outpatient department, after applying both inclusion and exclusion criteria, were enrolled in the present study. Majority (38.33 %) of patients had atrophic endometrium or normal endometrium. Endometrium was hyperplastic in 18 (30 %) patients, polyp in 6 (10 %) patients, and growth in 7 (11.67 %) patients. On histopathology, majority of patients (38.33 %) had atrophic endometrium. Endometrial hyperplasia was detected in 14 (23.33 %) out of which 11 had simple hyperplasia while 3 had atypical hyperplasia. Endometrial cancer was detected in 8 (13.33 %) patients. Out of 8 cases of endometrial malignancy, one case was confirmed as endometrial adenocarcinoma on histopathology.
CONCLUSION: Role of endometrial thickness cannot be undermined for detecting patients at high risk especially with comorbid conditions. Histo-pathological evaluation is mandatory for ruling out malignancy in selected cases of PMB through hysteroscopy.

Entities:  

Keywords:  Histological pattern of endometrium

Year:  2014        PMID: 26924906      PMCID: PMC4755942          DOI: 10.1007/s13224-014-0627-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  6 in total

1.  Transvaginal sonography and hysteroscopy in postmenopausal uterine bleeding.

Authors:  G Loverro; S Bettocchi; G Cormio; V Nicolardi; P Greco; A Vimercati; L Selvaggi
Journal:  Maturitas       Date:  1999-10-24       Impact factor: 4.342

2.  Hysteroscopy and transvaginal ultrasonography in postmenopausal women with uterine bleeding.

Authors:  G Garuti; I Sambruni; F Cellani; D Garzia; P Alleva; M Luerti
Journal:  Int J Gynaecol Obstet       Date:  1999-04       Impact factor: 3.561

3.  [Rating of transvaginal sonography in the evaluation of postmenopausal bleeding].

Authors:  B Gerber; A Krause; T Kuelz; A Quasmeh; T Reimer; K Friese
Journal:  Zentralbl Gynakol       Date:  1999

4.  Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding--a Nordic multicenter study.

Authors:  B Karlsson; S Granberg; M Wikland; P Ylöstalo; K Torvid; K Marsal; L Valentin
Journal:  Am J Obstet Gynecol       Date:  1995-05       Impact factor: 8.661

5.  Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer.

Authors:  B Gull; B Karlsson; I Milsom; S Granberg
Journal:  Am J Obstet Gynecol       Date:  2003-02       Impact factor: 8.661

6.  The role of hysteroscopy with eye-directed biopsy in postmenopausal women with uterine bleeding and endometrial atrophy.

Authors:  Raffaele Tinelli; Francesco G Tinelli; Ettore Cicinelli; Antonio Malvasi; Andrea Tinelli
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

  6 in total
  2 in total

1.  Abnormal Uterine Bleeding among Women Visiting Gynecology Out- patient Department of a Tertiary Care Hospital: A Descriptive Cross- sectional Study.

Authors:  Deepak Shrestha; Shreyashi Aryal; Archana Tiwari; Rupesh Sharma
Journal:  JNMA J Nepal Med Assoc       Date:  2022-02-15       Impact factor: 0.556

2.  The thin red line - postmenopausal abnormal uterine bleeding with endometrial thickness less than 4 mm.

Authors:  Magdalena Piróg; Olga Kacalska-Janssen; Tomasz Bereza; Robert Jach
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.